Page last updated: 2024-08-23

fosinopril and Kidney Diseases

fosinopril has been researched along with Kidney Diseases in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (50.00)18.2507
2000's3 (21.43)29.6817
2010's2 (14.29)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Geng, Z; Han, Y; Li, H; Wu, J; Xiong, Q; Xu, Y; Xu, Z; Zhou, J1
Craig, JC; Hahn, D; Hodson, EM1
Cohen, EP; Fish, BL; Moulder, JE1
Feng, Y; Huang, R; Li, X; Melgiri, ND; Qin, X; Sun, Y; Wang, Y1
Ao, X; Tang, R; Tang, TF; Zhou, QL; Zhu, LL1
Batlle, DC; Keilani, T; Schlueter, W1
Batlle, DC; Keilani, T; Levin, ML; Schlueter, WA1
Himeno, H; Hiroto, S; Minamisawa, K; Naruse, M; Shionoiri, H; Takasaki, I; Ueda, S1
Vetter, W1
Blumenthal, M1
Bak, AA; Crijns, HJ; de Jong, PE; Diercks, GF; Janssen, WM; van Boven, AJ; van Gilst, WH1
Aljama, P; Aranda, P; Diez, J; Marin, R; Ruilope, LM; Segura, J1
Shahinfar, S; Shaw, WC1
Chan, D; Duchin, KL; Hui, KK; Kramer, PK; Kripalani, KJ; Yanagawa, N1

Reviews

5 review(s) available for fosinopril and Kidney Diseases

ArticleYear
Interventions for preventing and treating kidney disease in IgA vasculitis.
    The Cochrane database of systematic reviews, 2023, 02-28, Volume: 2

    Topics: Adult; Child; Fosinopril; Humans; IgA Vasculitis; Kidney Diseases; Leflunomide; Proteinuria; Tacrolimus; Vasculitis

2023
Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bayes Theorem; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Follow-Up Studies; Fosinopril; Humans; Hypertension; Indoles; Kidney Diseases; Middle Aged; Patient Safety; Probability; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Young Adult

2017
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
    The American journal of cardiology, 1993, Dec-30, Volume: 72, Issue:20

    Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors

1993
Fosinopril. Clinical pharmacokinetics and clinical potential.
    Clinical pharmacokinetics, 1997, Volume: 32, Issue:6

    Topics: Absorption; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Interactions; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis

1997
Treatment of congestive heart failure: experience with fosinopril.
    American journal of hypertension, 1997, Volume: 10, Issue:10 Pt 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Enalaprilat; Exercise Tolerance; Fosinopril; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Diseases; Lisinopril; Male

1997

Trials

5 trial(s) available for fosinopril and Kidney Diseases

ArticleYear
Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril.
    The American journal of cardiology, 1993, Dec-30, Volume: 72, Issue:20

    Topics: Black People; Cholesterol; Diabetes Complications; Double-Blind Method; Fosinopril; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Proteinuria; Time Factors

1993
Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
    Annals of internal medicine, 1993, Feb-15, Volume: 118, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Proteinuria

1993
Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    American journal of hypertension, 1997, Volume: 10, Issue:10 Pt 2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cough; Creatinine; Drug Administration Schedule; Female; Fosinopril; Humans; Hypertension; Kidney Diseases; Male; Middle Aged

1997
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular E
    The American journal of cardiology, 2000, Sep-15, Volume: 86, Issue:6

    Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Diseases; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Research Design

2000
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease.
    Journal of hypertension, 2001, Volume: 19, Issue:10

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Female; Fosinopril; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Nifedipine; Prospective Studies

2001

Other Studies

5 other study(ies) available for fosinopril and Kidney Diseases

ArticleYear
Chitosan oligosaccharide alleviates renal fibrosis through reducing oxidative stress damage and regulating TGF-β1/Smads pathway.
    Scientific reports, 2022, 11-10, Volume: 12, Issue:1

    Topics: Animals; Chitosan; Fibrosis; Fosinopril; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Oligosaccharides; Oxidative Stress; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction

2022
Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
    International journal of radiation biology, 2014, Volume: 90, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone Marrow Transplantation; Calibration; Captopril; Enalapril; Fosinopril; Kidney; Kidney Diseases; Lisinopril; Male; Radiation Injuries; Ramipril; Rats; Renin; Renin-Angiotensin System; Whole-Body Irradiation

2014
[Effects of fosinopril and losartan on the expression of Toll- like receptor 4 in renal tubular epithelia cells].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2008, Volume: 33, Issue:10

    Topics: Animals; Cell Line; Epithelial Cells; Fosinopril; Hypertension; Kidney Diseases; Kidney Tubules; Losartan; Rats; RNA Interference; RNA, Messenger; Toll-Like Receptor 4

2008
Pharmacokinetics of fosinopril.
    Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Fosinopril; Humans; Kidney Diseases

1992
Pharmacokinetics of fosinopril in patients with various degrees of renal function.
    Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:4

    Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Female; Fosinopril; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Proline

1991